Navigation Links
MIGENIX Reports First Quarter Fiscal Year 2008 Financial Results
Date:9/11/2007

f 2008 and if the results of this trial are positive, Cadence submitting a new drug application (NDA) for Omigard in the first half of 2009; data from the celgosivir Phase II extension protocol being available by the end of 2007; 4-week interim results from the Phase II viral kinetics combination study of celgosivir in approximately 10 treatment-naive patients in October 2007; submitting an IND in the US in the first quarter of 2008 for the future development of celgosivir; Cutanea Life Sciences completing the Phase II CLS001 rosacea clinical trial in 2007; our estimate of the probable royalties payable to the holders of the convertible royalty participation units; the Company continuing to advance its highest priority programs while operating within an annual burn rate of $11 million to $13 million; and the Company's financial resources being sufficient to fund operations into the third quarter of calendar 2008.

With respect to the forward-looking statements contained in this news release, we have made numerous assumptions regarding, among other things: Cadence's ability to enroll sufficient patients to complete the Omigard CLIRS trial; the adequacy of the CLIRS trial design to generate data that are deemed sufficient by regulatory authorities to support potential regulatory filings, including an NDA, for Omigard; our ability to manage licensing opportunities; our ability to initiate, fund and complete non-clinical studies, clinical studies, manufacturing and all ancillary activities within our expected timelines; our partner Cutanea Life Sciences completing a Phase II CLS001 rosacea clinical trial in 2007; to and future expense levels being within our current expectations.

Actual results or events could differ materially from the plans, intentions and expectations expressed or implied in any forward-looking statements, including the underlying assumptions thereto, as a result of numerous risks, uncertainties and other factors including: dependence on c
'/>"/>

SOURCE MIGENIX Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related biology technology :

1. TomoTherapy reports 86% revenue jump, $131M net loss in Q1
2. Sonic Foundry reports GAAP loss as Q2 revenues rise
3. Fiserv reports $113.5 million in Q1 profit
4. Third Wave reports net loss of $18.9M for 2006
5. Musicnotes reports 45 percent growth in 2006
6. Sonic Foundry reports net loss, higher revenue
7. Sonic Foundry reports first cash-positive quarter
8. Merge Healthcare reports $10.8M net loss in Q3
9. Third Wave reports $5.2M third quarter loss
10. Merge Healthcare appoints new CEO, reports $215 million Q2 loss
11. Merge files financial reports by market opening
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/1/2014)... LA (PRWEB) August 01, 2014 Chantel Lee ... conduct research for 10 40-hour weeks with Dr. Juan Rodriguez, ... of diabetic retinopathy, a common diabetic eye disease caused by ... , "What Chantel and Eli accomplished is quite remarkable,” said ... only a concept when they started, and together carried it ...
(Date:8/1/2014)... 01, 2014 RURO, Inc., Laboratory ... today officially announces the opening of its first ... Park, Baoshan District in Shanghai, PRC, RURO Shanghai’s ... the management of Mr. Shen Gang, the former ... past three years, RURO’s has installed FreezerPro-based solutions ...
(Date:8/1/2014)... The  PROPEL Center  of the  iBIO Institute , dedicated ... life sciences companies in Illinois , ... help Illinois entrepreneurs attend ... Chicago .   AdvaMed 2014 is ... , bringing more than 1,000 companies together in ...
(Date:8/1/2014)... August 01, 2014 BCC Research ( ... DRUG DELIVERY: TECHNOLOGIES AND GLOBAL MARKETS , that the ... expected to grow to nearly $38.8 billion by 2018, ... 27.2%. The aptamer delivery category, the fastest moving segment ... CAGR. , The field of RNAi therapeutics has shown ...
Breaking Biology Technology:Two Centenary College Students Tackle Diabetic Retinopathy Research 2RURO Opens Office in Shanghai, China 2iBIO Institute's PROPEL Center Awards Grants for AdvaMed 2014 to Early-Stage Life Sciences Companies 2iBIO Institute's PROPEL Center Awards Grants for AdvaMed 2014 to Early-Stage Life Sciences Companies 3iBIO Institute's PROPEL Center Awards Grants for AdvaMed 2014 to Early-Stage Life Sciences Companies 4Global Market for RNAi Drug Delivery Technologies to Reach $38.8 Billion in 2018; Aptamer Delivery Segment Surging at 58.2% CAGR 2Global Market for RNAi Drug Delivery Technologies to Reach $38.8 Billion in 2018; Aptamer Delivery Segment Surging at 58.2% CAGR 3
... CPC of America, Inc.,(OTC Bulletin Board: CPCF.OB) today ... the investment banking subsidiary of FTI Consulting,Inc., to ... CPC of America,s financial advisor, FTI Capital Advisors ... from third parties seeking to,pursue a possible licensing ...
... ages who,have reached beyond the boundaries of their ... UCB today announced the winners of,its third ... awarded a,total of $300,000 in scholarships to 31 ... established to recognize individuals,of all ages who demonstrate ...
... NOMAD Bioscience GmbH,Munich, Germany (NOMAD) ... biomaterials and biopharmaceuticals that address critical ... of high-value products such as,nanopatterned materials, ... for important markets including biofuels, electric ...
Cached Biology Technology:CPC of America, Inc. to Explore Strategic Alternatives; Appoints FTI Capital Advisors to Assess Potential Opportunities 2UCB Scholarship Program Awards $300,000 to Students Living with Crohn's Disease 2UCB Scholarship Program Awards $300,000 to Students Living with Crohn's Disease 3UCB Scholarship Program Awards $300,000 to Students Living with Crohn's Disease 4UCB Scholarship Program Awards $300,000 to Students Living with Crohn's Disease 5Nomad Bioscience: New Plant Biotechnology Company Founded to Focus on Biomaterials and Biopharmaceuticals 2
(Date:7/31/2014)... that biomass burning burning forests to create ... slash-and-burn agriculture and wildfires figures into both ... the release of a new study by Stanford ... Jacobson, the degree of that contribution had never ... a paper published July 30 in the ...
(Date:7/31/2014)... NCT00518336) shows the sustained efficacy, immunogenicity and ... vaccine Cervarix. Women vaccinated with the HPV-16/18 ... nine years, and vaccine efficacy (VE) against ... longest follow-up report for a licensed HPV ... full paper. , HPV and vaccination ...
(Date:7/31/2014)... researchers have completed a 20-year study that looks ... at different times of the year. It finds ... time frame has no measurable negative consequences for ... benefits. , The study was conducted by Gene ... Station fire chief, and Joseph Craine, research assistant ...
Breaking Biology News(10 mins):Stanford professor finds that wildfires and other burns play bigger role in climate change 2Stanford professor finds that wildfires and other burns play bigger role in climate change 3Stanford professor finds that wildfires and other burns play bigger role in climate change 4Sustained efficacy, immunogenicity, and safety for GlaxoSmithKline's HPV vaccine 2Sustained efficacy, immunogenicity, and safety for GlaxoSmithKline's HPV vaccine 3Study finds benefits to burning Flint Hills prairie in fall and winter 2Study finds benefits to burning Flint Hills prairie in fall and winter 3
... gas used as an agricultural pesticide, was introduced in ... and increase fruit yields. Agricultural production nurseries around the ... plants for export and domestic sales. In 2000, the ... and in 2005 MB was banned in the United ...
... Children,s Mental Health Awareness Day on Thursday, the University ... Children (CSVAC) will host national experts at the scientific ... Violence Against Children." The two-day event, being held May ... findings on violence against children that will be published ...
... in German . , One of the ... enough environmentally friendly and resource-efficient energy to our society. ... importance. Bjrn Loges, Albert Boddien, Henrik Junge, and Matthias ... have now succeeded in the controlled extraction of hydrogen ...
Cached Biology News:Alternatives to ozone-depleting pesticide studied 2National scientific meeting on child mental health at Kentucky 2National scientific meeting on child mental health at Kentucky 3Power from formic acid 2